Keywords: compassionate-use, ind, pro-pharm, davant, glycosciences, firm, pro-pharmaceuticals
"Compassionate-use" IND for Pro-Pharm's Davant
Article | 03 September 2007
US glycosciences firm Pro-Pharmaceuticals says that the Food and Drug Administration has granted a "compassionate use" Investigational New Drug application ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
